TheIn VitroInhibition of Human CYP1A2, CYP2D6 and CYP3A4 by Tetrahydropalmatine, Neferine and Berberine
Authors:
- 16 June 2011
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 26 (2) , 277-283
Abstract
The purpose of this study was to investigate thein vitroinhibition potential of the three purified herbal constituents tetrahydropalmatine (Tet), neferine (Nef) and berberine (Ber) towards recombinant human CYP1A2, CYP2D6 and CYP3A4 metabolic activities.In vitroincubations were performed with phenacetin, dextromethorphan and testosterone, respectively, as CYP substrates and their metabolites were determined by validated HPLC methods. Positive control inhibitors were run for each CYP in all incubation series. Inhibition was expressed by IC50values. All herbal constituents demonstrated some, but variable, inhibition potencies towards the investigated CYP enzymes. CYP2D6 was the most sensitive for inhibition and then mainly by Tet and Ber with IC50values of 3.04 ± 0.26 µmand 7.40 ± 0.36 µm, respectively. CYP3A4 and especially CYP1A2 were inhibited to a much smaller extent by all constituents. Neferine showed the lowest overall interaction potential towards the CYP enzymes investigated. The CYP inhibition potential for the purified constituents could be related to their chemical structures. No clinical significant metabolic interaction seems likely to occur between the CYP enzymes and herbal constituents tested, with a possible exception for the CYP2D6 inhibition by Tet and Ber. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Investigation of the Interaction between Berberine and Human Serum AlbuminBiomacromolecules, 2009
- Effects of plant extract neferine on cyclic adenosine monophosphate and cyclic guanosine monophosphate levels in rabbit corpus cavernosum in vitroAsian Journal of Andrology, 2008
- Potential Interactions Between Complementary/Alternative Products and Conventional Medicines in a Medicare PopulationAnnals of Pharmacotherapy, 2007
- The Induction of CYP1A2, CYP2D6 and CYP3A4 by Six Trade Herbal Products in Cultured Primary Human HepatocytesBasic & Clinical Pharmacology & Toxicology, 2006
- Chiral liquid chromatography resolution and stereoselective pharmacokinetic study of tetrahydropalmatine enantiomers in dogsJournal of Chromatography B, 2005
- IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACTDrug Metabolism and Disposition, 2004
- The Induction of Cytochrome P450 3A5 (CYP3A5) in the Human Liver and Intestine Is Mediated by the Xenobiotic Sensors Pregnane X Receptor (PXR) and Constitutively Activated Receptor (CAR)Journal of Biological Chemistry, 2004
- HUMAN CYTOCHROME P450 INHIBITION AND METABOLIC-INTERMEDIATE COMPLEX FORMATION BY GOLDENSEAL EXTRACT AND ITS METHYLENEDIOXYPHENYL COMPONENTSDrug Metabolism and Disposition, 2003
- THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEDrug Metabolism and Disposition, 2003
- Harmless Herbs? A Review of the Recent LiteratureThe American Journal of Medicine, 1998